Sunday, September 23, 2018

Proof-of-concept HIV immunotherapy study passes Phase 1 safety trial

Preliminary results from a phase I clinical trial have demonstrated the safety and tolerability of a cell therapy involving the ex vivo expansion of T cells and their subsequent infusion into HIV-infected individuals previously treated with antiretroviral therapy (ART).

from Top Health News -- ScienceDaily https://ift.tt/2OMAuMO
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

New drugs could wipe out the “zombie cells” linked to cancer and aging

Researchers found a new way to kill harmful “zombie” cells that linger after chemotherapy and help cancers become more aggressive. These sen...